MedTrace Logo

Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis

NCT00675779 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2008-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether atorvastatin (alone or in combination with oral contraceptive) is effective in treatment of pelvic pain and inflammatory response in women with endometriosis.

Conditions

  • Endometriosis
  • Pain

Interventions

DRUG

oral contraceptive (Mercilon)

oral contraceptive (20ug EE, 150ug DSG) 1 tablet a day p.o. for 21 days with 7 day break for 6 months

DRUG

atorvastatin + oral contraceptive

atorvastatin 20mg po a day for 6 months + oral contraceptive (20ug EE, 150ug DSG) 1 tablet po a day for 21 days with 7 day break for 6 months

Sponsors & Collaborators

  • University of California, Davis

    collaborator OTHER

  • Biomet Polska Sp. z.o.o.

    collaborator INDUSTRY

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Antoni J Duleba, MD · University of California, Davies, USA

  • Leszek Pawelczyk, MD PhD · Poznan University of Medical Sciences, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-11-30
Completion
2011-03-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00675779 on ClinicalTrials.gov